Clinical Trials

35 enrolled

Melanoma

NCT04745234 2024-04-25

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

34 enrolled

DermatologicLymphoid

Recurrence, Lymphoma, T-Cell, Cutaneous

NCT02232516 2024-04-10

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

30 enrolled 17 charts

DermatologicLymphoid

Immunoblastic Lymphadenopathy, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT04879654 2024-03-05

SNMM

45 enrolled

Melanoma

NCT05135715 2024-02-20

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

50 enrolled

Melanoma

NCT02977052 2023-11-15

OpACIN-neo

186 enrolled

Melanoma

NCT05234658 2023-11-08

Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery

21 enrolled

Carcinoma, Basal Cell

NCT05370807 2023-10-24

RegoMel

48 enrolled

Melanoma

NCT04362722 2023-10-10

DUNCAN

Carcinoma, Carcinoma, Basal Cell

NCT05329792 2023-10-06

IntriNSiC

70 enrolled

DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

NCT02858921 2023-08-30

Neo Trio

60 enrolled

Melanoma, Neoplasms

NCT03808441 2023-08-25

CAcTUS

21 enrolled

Melanoma

NCT05907512 2023-06-22

Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma

43 enrolled

Melanoma

NCT05106023 2023-06-07

To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma

31 enrolled

Melanoma

NCT05263453 2023-05-31

HL-085+Vemurafenib to Treat Advanced Melanoma Patients With BRAF V600E/K Mutation

104 enrolled

Melanoma

NCT05823246 2023-05-26

Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma

DermatologicGenitourinary

66 enrolled

Carcinoma, Transitional Cell, Melanoma

NCT05854589 2023-05-11

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

20 enrolled

Melanoma

NCT05827770 2023-04-25

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

20 enrolled

Melanoma

NCT03528408 2023-04-11

Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma

52 enrolled

Uveal Melanoma, Melanoma

NCT03769285 2023-04-06

SPRINTR-Pilot

120 enrolled

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT03132675 2023-03-27

Keynote-695

143 enrolled

Melanoma

NCT05767879 2023-03-14

(Neo)Adjuvant BRAF/MEK Inhibition in pN1c Melanoma

28 enrolled

Melanoma

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

441 enrolled

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT05740969 2023-02-23

PACKS

48 enrolled

Keratosis, Actinic

NCT03913923 2023-02-10

OBERTON

117 enrolled

Melanoma

NCT05664139 2023-02-08

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

30 enrolled

Melanoma

NCT04633902 2022-12-06

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

41 enrolled

Melanoma

NCT05077280 2022-12-06

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

Uveal Melanoma, Neoplasm Metastasis

NCT05051865 2022-11-17

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

60 enrolled

Melanoma

NCT05406466 2022-11-10

Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis

25 enrolled

Melanoma

NCT02036086 2022-10-27

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

24 enrolled

Melanoma

NCT04913025 2022-09-21

REFINE

DermatologicGenitourinary

160 enrolled

Carcinoma, Renal Cell, Melanoma

NCT04929535 2022-08-30

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

51 enrolled

Carcinoma, Basal Cell

NCT03780608 2022-06-15

This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)

61 enrolled

Melanoma

NCT05104801 2021-11-04

Sitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic Melanoma

37 enrolled

Melanoma

NCT05097378 2021-10-28

PREMIUM

45 enrolled

Melanoma, Neoplasms

NCT03925350 2021-10-22

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

41 enrolled

Melanoma

NCT04979585 2021-08-03

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

66 enrolled

Melanoma

NCT04928365 2021-06-16

Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy

50 enrolled

Melanoma

NCT04884997 2021-05-13

A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma

90 enrolled

Melanoma

NCT03313323 2021-04-15

Zirconipi

29 enrolled

Melanoma

NCT02501551 2021-04-05

Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

36 enrolled

Melanoma

NCT02617849 2021-02-18

Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma

30 enrolled

Melanoma

NCT04749485 2021-02-11

A Study of HX008 for the Treatment of Patients With Malignant Melanoma

119 enrolled

Melanoma

NCT04593485 2020-12-23

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Melanoma

NCT03013101 2020-09-30

Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma

128 enrolled

Melanoma, Neoplasm Metastasis

NCT03269565 2020-09-18

MIRACULUM

126 enrolled

Melanoma

NCT03544723 2020-06-09

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Liver Neoplasms, Lymphoma, Melanoma, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04397770 2020-05-21

Camrelizumab Plus Apatinib and Temozolomide as First Line Therapy in Advanced Acral Melanoma

Melanoma

NCT02533700 2020-03-10

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL